Zenotech Laboratories Share Price

CMP as on22-Jan-21 15:33

₹ 31.20
-0.65 -2.04%

Open

₹ 31.85

Turnover (lac)

₹ 2

Prev. Close

₹ 31.85

Day's Vol (shares)

₹ 14,634

Day's Range

₹ 30.50
₹ 32.45

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 13-Jan-2021 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2021 ,inter alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2020. Further, kindly note that pursuant to the Companys Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on January 01, 2021, and shall end on January 25, 2021 i.e. after 48 hours of the declaration of financial results of the Company on January 23, 2021. This is for your information and records.
Board Meeting - 23-Oct-2020 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2020 ,inter alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2020. Further, kindly note that pursuant to the Companys Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on October 01, 2020, and shall end on November 02, 2020 i.e. after 48 hours of the declaration of financial results of the Company on October 31, 2020. This is for your information and records. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Saturday, October 31, 2020, have approved and took on record the limited review Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2020, which are enclosed herewith along with the Limited Review Report of the Statutory Auditors of the Company on Standalone Unaudited Financial Results. The meeting of the Board of Directors of the Company commenced at 11:30 a.m. and concluded at 2:45 p.m. We request you to take the above on record. (As Per BSE Announcement dated on 31.10.2020)
Board Meeting - 19-Jul-2020 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2020 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2020. Pursuant to the provisions of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors (the Board) of the Company at its meeting held today, i.e. Saturday, July 25, 2020, have, inter-alia, duly approved and took on record, the following: 1) Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2020, is enclosed as Annexure. 2) Limited Review Report issued by our Statutory Auditors, M/s. PKF Sridhar & Santhanam LLP, Chartered Accountants, Hyderabad, is enclosed as Annexure; and 3) Re-appointment of M/s. PKF Sridhar & Santhanam LLP (Firm Registration No. 003990S/S 200018) as Statutory Auditors of the Company for second term of five years 4) The Board has authorised the management to take appropriate actions for initiating the process of winding up of Zenotech Inc, a subsidiary of the Company. Pursuant to the provisions of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors (the Board) of the Company at its meeting held today, i.e. Saturday, July 25, 2020, have, inter-alia, duly approved and took on record, the following: The Board has authorized the management to take appropriate actions for initiating the process of winding up of Zenotech Inc., a subsidiary of the Company (As Per BSE Announcement Dated 25.07.2020)
Board Meeting - 20-May-2020 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2020 ,inter alia, to consider and approve the Audited Standalone Financial Results of the Company for the fourth quarter and year ended March 31, 2020. Further, kindly note that pursuant to the Companys Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on April 01, 2020, and shall end on May 25, 2020 i.e. after 48 hours of the declaration of financial results of the Company on May 23, 2020. A copy of this intimation is also being made available on the website at www.zenotechlab.com. This is for your information and records.
Board Meeting - 23-Jan-2020 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2020 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2019. Pursuant to the provisions of Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on today, i.e. February 1, 2020, has considered and approved, inter-alia, the following items: 1. Unaudited Financial Results of the Company along with Limited Review Report issued by the Statutory Auditors for the quarter and nine months ended December 31, 2019. The financial results and Limited Review Report has been enclosed as Annexure A Pursuant to the provisions of Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on today, i.e. February 1, 2020, has considered and approved, inter-alia, to obtain approval of the Members under Section 13 & 27 and all other applicable provisions of the Companies Act, 2013 and rules made thereunder for variation in the terms of Objects of the Issue which is less than 10% of the Rights Issue mentioned in the Letter of Offer dated June 21, 2017 of the Company by way of Postal Ballot Pursuant to the provisions of Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on today, i.e. February 1, 2020, has considered and approved, inter-alia, the following items: 1. Unaudited Financial Results of the Company along with Limited Review Report issued by the Statutory Auditors for the quarter and nine months ended December 31, 2019. The financial results and Limited Review Report has been enclosed as Annexure A Pursuant to the provisions of Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on today, i.e. February 1, 2020, has considered and approved, inter-alia, to obtain approval of the Members under Section 13 & 27 and all other applicable provisions of the Companies Act, 2013 and rules made thereunder for variation in the terms of Objects of the Issue which is less than 10% of the Rights Issue mentioned in the Letter of Offer dated June 21, 2017 of the Company by way of Postal Ballot; (As Per BSE Announcement Dated 01.02.2020)